
Owner, Aria Cosmetic and Reconstructive Surgery
Member of the Healthcare Council
Robert Frank, MD, is a board certified Plastic Surgeon in private practice in Northwest Indiana. Dr. Frank has extensive expertise in general and plastic surgery procedures entering practice in 1997. He has special interest in breast and body contouring procedures, particularly cosmetic breast surgery. Dr. Frank has used both Allergan and Mentor breast implants, and has been an investigator with the adjunct studies of both manufacturers. Since widespread reintroduction of silicone gel implants in November 2006, Dr. Frank has become one of the biggest users of silicone gel implants in the state. He is also experienced in nonsurgical plastic surgery procedures, including use of fillers, such as, Restylane, Juvederm, and Sculptra, and Botox. Dr. Frank has also used Alloderm, Collamend, FlexHD, and other similar graft products. He is a member of American Society of Plastic Surgeons, American Society of Aesthetic Plastic Surgery, and a Fellow of American College of Surgeons. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Mentor/J&J deal is long overdue
December 3, 2008
Johnson & Johnson buys medical device maker | www.nytimes.com
The purchase of implant manufacturer, Mentor Corporation, by Johnson and Johnson will level the playing field as Mentor seeks to take market share from Allergan in both the breast implant business as well as facial fillers and competitors to Botox.
Dermatologists? I worry more about the Family practitioners, Ob-Gyns, and Internists...
July 31, 2008
As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
As insurance reimbursements decline, everyone suddenly thinks they're a cosmetic surgeon.
Phase 2 trials show significantly improved scars
March 14, 2008
Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery | www.renovo.com
Juvista appears to be effective in improving scar quality according to recently released Phase II results. Renovo reported no clinical improvement in breast augmentation scars treated with a single injection of the drug.
Botox competitors can't come soon enough
February 7, 2008
Efficacy of Botulinum Toxin Does Not Sag Over Time | www.medscape.com
Botox from Allergan has enjoyed an exclusive monopoly for the past nine years. Alternative drugs do not appear to be available as soon as was hoped.
Credit crunch may effect healthcare financing
September 13, 2007
Doctors Offering No-Interest Loans to Patients | www.nytimes.com
Changes in the credit market, specifically the subprime market, may impact companies clamoring to finance elective healthcare and cosmetic procedures. This may impact the number of patients ultimately undergoing these expensive procedures.
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Physicians who Perform Breast Implant Surgery | 190 |
| Physicians who Implant Silicone Breast Implants | 150 |
| Juvederm Users: Cosmetic Dermatologists (US) | 133 |
Robert Frank has not participated in any GLG Live Meetings.